» Articles » PMID: 15939040

Effects of ML-7 and Y-27632 on Carbachol- and Endothelin-1-induced Contraction of Bovine Trabecular Meshwork

Overview
Journal Exp Eye Res
Specialty Ophthalmology
Date 2005 Jun 9
PMID 15939040
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The trabecular meshwork is considered a smooth muscle like tissue contributing to aqueous outflow regulation and thus to regulation of intraocular pressure. An elevation in intraocular pressure is one of the greatest risk factors for most forms of glaucoma. We assume that contraction of trabecular meshwork reduces aqueous humor outflow and thus enhances intraocular pressure, whereas relaxation exerts the opposite effect. The present paper supports the hypothesis of the trabecular meshwork being a smooth muscle-like tissue. We perform measurements of isometric force in isolated bovine trabecular meshwork strips. Contractility of this tissue is induced by carbachol or endothelin-1. The contractile force is successfully inhibited by ML-7, a highly specific inhibitor of myosin light chain kinase. The contraction is also reduced in the presence of the RhoA kinase inhibitor Y-27632. We further describe the protein expression of smooth muscle myosin and its regulatory kinase, the myosin light chain kinase, in human and bovine trabecular meshwork cells. Additionally, the serine phosphorylation of myosin light chain kinase is shown. These data indicate that the trabecular meshwork expresses major contractility regulating proteins which are involved in tissue function. Inhibition of the signaling pathways which lead to myosin phosphorylation causes inhibition of contractile force in trabecular meshwork. According to our concept of aqueous humor outflow regulation, trabecular meshwork relaxing substances appear to be ideal antiglaucomatous drugs, leading to increased outflow facility.

Citing Articles

Mechanistic Effects of Baicalein on Aqueous Humor Drainage and Intraocular Pressure.

Li H, Shan S, Stamer W, Li K, Chan H, Civan M Int J Mol Sci. 2022; 23(13).

PMID: 35806375 PMC: 9266486. DOI: 10.3390/ijms23137372.


Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2.

Callaghan B, Lester K, Lane B, Fan X, Goljanek-Whysall K, Simpson D Sci Rep. 2022; 12(1):9564.

PMID: 35689009 PMC: 9187693. DOI: 10.1038/s41598-022-13573-8.


Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies.

Sharif N Front Pharmacol. 2021; 12:729249.

PMID: 34603044 PMC: 8484316. DOI: 10.3389/fphar.2021.729249.


The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissues associated with glaucoma pathogenesis.

Sundberg C, Lakk M, Paul S, Figueroa K, Scoles D, Pulst S J Comp Neurol. 2021; 530(2):537-552.

PMID: 34350994 PMC: 8716417. DOI: 10.1002/cne.25228.


TRPV4-Rho signaling drives cytoskeletal and focal adhesion remodeling in trabecular meshwork cells.

Lakk M, Krizaj D Am J Physiol Cell Physiol. 2021; 320(6):C1013-C1030.

PMID: 33788628 PMC: 8285634. DOI: 10.1152/ajpcell.00599.2020.